VOLORIDGE INVESTMENT MANAGEMENT, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$31,746,062
+118.5%
311,358
+94.8%
0.15%
+108.3%
Q1 2023$14,530,471
+75.6%
159,816
-26.6%
0.07%
+56.5%
Q4 2022$8,276,008
+3.0%
217,847
-31.9%
0.05%
+7.0%
Q3 2022$8,036,000
+20.8%
319,780
+46.1%
0.04%
+26.5%
Q2 2022$6,651,000
-20.2%
218,853
-13.9%
0.03%
-27.7%
Q1 2022$8,331,000
-2.1%
254,305
-21.2%
0.05%0.0%
Q4 2021$8,507,000
-15.3%
322,586
+354.4%
0.05%
-32.9%
Q2 2021$10,047,000
+503.8%
70,990
+325.4%
0.07%
+483.3%
Q1 2021$1,664,000
+300.0%
16,689
+479.5%
0.01%0.0%
Q1 2020$416,000
-86.0%
2,880
-80.2%
0.01%
-79.3%
Q4 2019$2,971,000
+558.8%
14,532
+175.6%
0.06%
+314.3%
Q1 2019$451,0005,2720.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders